How Does Finasteride Work?
In men with hereditary hair loss, the hormone DHT plays a central role. It attaches to receptors in hair roots and triggers a gradual shrinking process. Finasteride targets this mechanism directly: it blocks the enzyme 5-alpha-reductase (type II), which is responsible for converting testosterone to DHT. [1]
DHT binds to androgen receptors approximately ten times more strongly than testosterone and is the main cause of hair follicle miniaturization. By reducing DHT levels by approximately 70%, finasteride slows miniaturization and allows shrunken follicles to produce stronger hairs again. [2]
In addition to DHT reduction, finasteride also influences cellular processes in the hair follicle. It reduces the activity of pro-apoptotic enzymes (caspases) involved in cell death while increasing protective proteins such as XIAP and Bcl-2. These effects help preserve hair follicles and extend the growth phase (anagen).
Efficacy
The efficacy of finasteride is well documented through extensive clinical studies. In a large study of over 1,500 men, 48% of the finasteride group showed improvement after 12 months, compared to only 7% in the placebo group. [1] Hair counts increased or stabilized in the treatment group, while the placebo group continued to lose hair.
Long-term studies over 5 years confirm that most patients can maintain or further improve their hair density. [2] Effects typically begin after 3-6 months and reach their maximum after about 2 years of continuous use. For optimal results, finasteride can be combined with minoxidil, as both active ingredients work through different mechanisms.
Interestingly, studies show that lower dosages can also be effective. A 48-week study found that 54% of men on 0.2 mg daily showed improvement, compared to 58% on 1 mg. [5] This suggests that for some individuals, a lower dose could be an alternative to minimize potential side effects.
Oral Versus Topical Application
Oral finasteride at the standard dose of 1 mg daily reduces blood DHT levels by approximately 70% and scalp DHT by 62-72%. [3] This systemic effect is very effective but may cause side effects in some individuals.
Topical finasteride offers an alternative with potentially lower systemic absorption. Studies show that topical formulations with approximately 0.1-0.9 mg daily exposure can reduce scalp DHT levels by 68-75%, comparable to the oral form. At the same time, systemic absorption is significantly lower, potentially reducing the risk of side effects. [3]
Start your online consultation now or learn about our treatment options.
Safety and Side Effects
Finasteride is generally well tolerated. The original approval studies showed sexual side effects in 1.8% of men on finasteride, compared to 1.3% on placebo. [1] This means only about 0.5% of users are actually affected due to the medication.
The most commonly reported side effects include decreased libido, erectile dysfunction, and ejaculatory disorders. According to study data, these effects are reversible: when the medication is discontinued, values typically normalize within 2-3 months. It is also noteworthy that many men who experience side effects in the first 2-3 months report spontaneous improvement with continued treatment.
Regarding long-term safety, studies involving over 30,000 men with 18 years of follow-up show that finasteride can reduce the risk of prostate cancer by approximately 25%. [4] Contrary to earlier concerns, finasteride does not increase the risk of high-grade prostate cancer, but rather facilitates its detection through prostate shrinkage.
Application
The standard dosage is 1 mg once daily, regardless of meals. The tablet should be swallowed whole and not split, as the active ingredient can be absorbed through skin contact. For individuals concerned about side effects, a lower dose (0.2-0.5 mg) may be considered under medical supervision.
Treatment requires patience: first visible results typically appear after 3-6 months, with maximum effects only after 1-2 years. After discontinuation, hair loss returns within 3-12 months, as finasteride controls the genetic predisposition but does not eliminate it.
Approved Uses
- Androgenetic alopecia (male pattern hair loss)
- Benign prostatic hyperplasia (BPH)
Drug Category
5-Alpha-Reductase InhibitorDosage
| Form | Strength | Frequency | Prescription Required |
|---|---|---|---|
| Oral (Tablet) | 1 mg | 1x daily | Yes |
| Oral (Tablet, low dose) | 0.2-0.5 mg | 1x daily | Yes |
| Topical (Solution) | 0.005-0.25% | 1x daily | Yes |
Side Effects
Common Side Effects
- Decreased libido (0.5-1.8%)
- Erectile dysfunction (0.5-1.3%)
- Ejaculatory disorders (0.4-1.2%)
Uncommon Side Effects
- Breast tenderness or enlargement
- Skin rash
- Mood changes
Rare Side Effects
- Depressed mood
- Testicular pain
- Hypersensitivity reactions
Find the right treatment?
Start nowNot suitable for
- Women (especially pregnant and breastfeeding)
- Hypersensitivity to finasteride
- Severe liver disease
- Children and adolescents under 18 years
Warnings & Precautions
Women should not handle crushed or broken tablets as finasteride can be absorbed through the skin
Prostate cancer should be ruled out before starting treatment
Finasteride can lower PSA values by approximately 50%, which must be considered when interpreting prostate cancer screenings
Effects can only be assessed after 3-6 months of regular use
Hair loss returns after discontinuation
FAQs
References
- [1] Kaufman KD, Olsen EA, Whiting D, et al.. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. https://doi.org/10.1016/s0190-9622(98)70007-6
- [2] Zito PM, Bistas KG, Syed K. (2024). Finasteride. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513329/
- [3] Piraccini BM, Blume-Peytavi U, Scarci F, et al.. (2022). Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.17738
- [4] Goodman PJ, Tangen CM, Darke AK, et al.. (2019). Long-Term Effects of Finasteride on Prostate Cancer Mortality. The New England Journal of Medicine. https://doi.org/10.1056/NEJMc1809961
- [5] Fertig RM, Caresse GA, Darwin E, Gaudi S. (2017). Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: a comprehensive review. Dermatology Online Journal. https://doi.org/10.5070/D32311037240